Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Gastrointestinal 1Endocrine 1

Conditions

Carcinoma, Non-Small-Cell Lung 24Brain Neoplasms 19Neoplasm Metastasis 13Lung Neoplasms 13Pancreatic Neoplasms 11Melanoma 10Carcinoma, Renal Cell 9Carcinoma, Hepatocellular 9Squamous Cell Carcinoma of Head and Neck 6Small Cell Lung Carcinoma 6Prostatic Neoplasms 6Neoplasms 6Glioblastoma 6Breast Neoplasms 6Liver Neoplasms 5Head and Neck Neoplasms 4Glioma 3Colorectal Neoplasms 3Uveal Melanoma 2Sarcoma 2Mesothelioma 2Gliosarcoma 2Gastrointestinal Neoplasms 2Cholangiocarcinoma 2Wilms Tumor 1Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor 1Spinal Cord Compression 1Secondary Malignant Neoplasm of Liver 1Sarcoma, Ewing 1

Interventions

Adrenalectomy 2pertuzumab 1Surgical Procedures, Operative 1Radiosurgery 1Observation 1Nivolumab 1Erlotinib Hydrochloride 1Cryosurgery 1(18F)GTP1 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Adrenal Gland Neoplasms × Radiosurgery × Clear all
NCT04785287 2026-03-03

Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

M.D. Anderson Cancer Center

Phase 1/2 Terminated
13 enrolled
EndocrineGastrointestinalThoracic

Adrenal Gland Neoplasms, Carcinoma, Hepatocellular, Liver Neoplasms, Lung Neoplasms, Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡